BCL-6 co-repressor (BCOR) mutations occur in ~ 3–6% of AML [3], enriched in RUNX1-mutant or secondary AML following myelodysplastic syndromes [4]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.